- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- STAT-6 siRNA Demonstrates Efficacy in Immunology
- Grant of MK Cell Patent & Licencing Update
- Results of AGM
- Appointment of Broker
- Notice of Annual General Meeting
- Issue of Convertible Loan Notes & Board Changes
- Midkine Antibody Licencing Deal
- Annual Report & Financial Statements - 31 Dec 2023
- Response to Share Price Movement
- Positive Results: Midkine mRNA and STAT-6 siRNA
More ▼
Key statistics
On Friday, Roquefort Therapeutics PLC (ROQ:LSE) closed at 3.60, 9.09% above its 52-week low of 3.30, set on Sep 18, 2024.
52-week range
Open | 3.60 |
---|---|
High | 3.78 |
Low | 3.60 |
Bid | 3.50 |
Offer | 4.00 |
Previous close | 3.60 |
Average volume | 192.05k |
---|---|
Shares outstanding | 129.15m |
Free float | 51.14m |
P/E (TTM) | -- |
Market cap | 4.65m GBP |
EPS (TTM) | -- |
Data delayed at least 20 minutes, as of Sep 20 2024 14:29 BST.
More ▼